Long Covid Newsletter
Issue #7October 20, 20257 studies

1 in 3 COVID survivors in Rwanda still have symptoms, plus new insights on inflammation and recovery

1 in 3 COVID survivors in Rwanda still have symptoms, plus new insights on inflammation and recovery

Monday, Monday, October 20th Long Covid Newsletter Issue #7

New research is painting a clearer picture of long COVID's global reach and biological mechanisms. From Rwanda to Sweden, scientists are uncovering who's most at risk and why some people can't shake persistent symptoms.

🌍 Rwanda Study Reveals Long COVID's Global Impact

A nationally representative survey of 3,143 adult COVID survivors in Rwanda found that 34% still experience persistent symptoms months after infection.

  • The most common lingering issues were back pain, headache, dizziness, fatigue, and reduced sexual desire

  • Women, adults over 35, and people with multiple COVID infections had higher odds of long COVID, while those with anxiety were also at increased risk

  • Surprisingly, COVID vaccination showed no association with long COVID risk in this population

Why this matters: This is one of the first large-scale studies from sub-Saharan Africa, showing long COVID isn't just a problem in wealthy countries. With one-third of survivors affected, healthcare systems worldwide need to prepare for long-term care needs.

Top 50% journal πŸ”— IJID Regions πŸ—“οΈ Oct 10

Key Findings

πŸ”¬ Inflammation During Acute COVID Predicts Long-Term Fatigue

Researchers tracked 54 hospitalized COVID patients and found that specific inflammatory markers during the acute phase predicted who would have chronic fatigue 6-9 months later. Higher levels of IL-1RA, IFN-Ξ³, TNF-Ξ±, and monocyte percentage during the initial infection were linked to increased physical and total fatigue scores later on.

πŸ’‘ Your body's initial inflammatory response may set the stage for long-term exhaustion.
Top 20% journal πŸ”— Brain, Behavior, and Immunity - Health πŸ—“οΈ Oct 10

πŸ’Š Anti-Inflammatory Drugs May Prevent Post-COVID Depression

In a study of 588 COVID survivors, those treated with cytokine-blocking drugs (like anakinra and tocilizumab) during their acute illness had less severe depression symptoms and were less likely to develop clinical depression later. The protective effect worked by reducing systemic inflammation, measured by a marker called the systemic inflammation index.

πŸ’‘ Blocking inflammation early might prevent the mental health toll of long COVID.
Top 20% journal πŸ”— Journal of Neuroimmune Pharmacology πŸ—“οΈ Oct 10

πŸ«€ Blood Vessel Protein Elevated in Long COVID, Especially Postmenopausal Women

Scientists analyzed 1,395 protein biomarkers in 171 people and discovered that VEGFA, a protein involved in blood vessel function, was significantly overexpressed in long COVID patients. The effect was particularly pronounced in postmenopausal women, suggesting hormonal status plays a role in vascular dysfunction after COVID.

πŸ’‘ Long COVID may be fundamentally a vascular disease, with sex hormones influencing recovery.
πŸ₯‰ Top 5% journal πŸ”— BMC Medicine πŸ—“οΈ Oct 11

πŸƒβ€β™€οΈ Exercise Capacity Remains Impaired Six Months Later

A study comparing 94 long COVID patients to 100 recovered patients and 70 healthy controls found persistent exercise problems. Long COVID patients had significantly reduced oxygen consumption (70.1% of predicted normal) and walked shorter distances (484 meters vs 607 meters for recovered patients) on a 6-minute walk test. These impairments showed no improvement over six months.

πŸ’‘ Long COVID's exercise intolerance isn't just temporaryβ€”it may require targeted rehabilitation.
Top 50% journal πŸ”— Respiratory Physiology and Neurobiology πŸ—“οΈ Oct 11

πŸ“± Wearable Devices Could Track Fatigue Across Chronic Diseases

A systematic review found that digital biomarkers from wearable devices consistently correlate with fatigue across 13 different chronic conditions, including long COVID, multiple sclerosis, and cancer. Reduced physical activity, increased sedentary behavior, and signs of autonomic nervous system dysfunction were common patterns linked to fatigue levels.

πŸ’‘ Your smartwatch data might soon help doctors personalize fatigue management across many conditions.
πŸ₯ˆ Top 2% journal πŸ”— npj Digital Medicine πŸ—“οΈ Oct 8

πŸ—£οΈ Swedish Experts Divided on Long COVID Diagnosis

Interviews with 36 Swedish healthcare experts revealed significant disagreements about long COVID as a medical diagnosis. While all agreed patients need care, they disagreed on whether it's a unique condition requiring specialized treatment or similar to other post-viral syndromes. Experts also noted concerning demographics: white Swedish women were overrepresented among patients, while migrants and elderly were largely absent from care.

πŸ’‘ Long COVID isn't just a medical issueβ€”it's become a political battleground affecting who gets care.
πŸŽ–οΈ Top 10% journal πŸ”— Health Expectations πŸ—“οΈ Oct 7

Implications

These studies reveal long COVID as a complex, multi-system condition affecting millions globally, with inflammation and vascular dysfunction as key drivers. The research suggests early intervention with anti-inflammatory treatments might prevent some long-term complications, while highlighting concerning disparities in who receives care and recognition.

Studies in this issue

Primary sources used for this newsletter.

  1. Experts' differing views on diagnosing long-term COVID-19 symptoms in Sweden
    key findingHealth expectations : an international journal of public participation in health care and health policy2025-10-07PMID 41054864
  2. Digital signs of fatigue in long-term illnesses: a systematic review
    key findingNPJ digital medicine2025-10-08PMID 41062803
  3. Inflammation linked to fatigue after COVID-19
    key findingBrain, behavior, & immunity - health2025-10-10PMID 41070112
  4. Blocking Immune Signals May Reduce Inflammation and Improve Depression After COVID-19
    key findingJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2025-10-10PMID 41071398
  5. Breathing and energy limits in people with long COVID
    key findingRespiratory physiology & neurobiology2025-10-11PMID 41075953

Continue reading

All Long Covid issues